BRPI0518399A2 - produÇço de beta-lactama - Google Patents

produÇço de beta-lactama

Info

Publication number
BRPI0518399A2
BRPI0518399A2 BRPI0518399-5A BRPI0518399A BRPI0518399A2 BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2 BR PI0518399 A BRPI0518399 A BR PI0518399A BR PI0518399 A2 BRPI0518399 A2 BR PI0518399A2
Authority
BR
Brazil
Prior art keywords
beta
lactam
production
lactam production
lactam compounds
Prior art date
Application number
BRPI0518399-5A
Other languages
English (en)
Inventor
Den Berg Marco Alexander Van
Roelof Ary Lans Bovenberg
Hendrik Jan Noorman
Bastiaan Romein
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0518399A2 publication Critical patent/BRPI0518399A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PRODUÇAO DE BETA-LACTAMA. A invenção atual descreve a transformação de um microrganismo que não produza naturalmente um composto do beta-lactam com os polinucleotídeos envolvidos no biosynthesis de compostos do beta-lactam e no uso de tais microrganismos transformados na produção de compostos do beta-lactam ou na identificação dos genes ou dos fatores envolvidos na síntese de um composto do beta-lactam.
BRPI0518399-5A 2004-12-10 2005-12-08 produÇço de beta-lactama BRPI0518399A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106471 2004-12-10
PCT/EP2005/056619 WO2006061425A2 (en) 2004-12-10 2005-12-08 Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms

Publications (1)

Publication Number Publication Date
BRPI0518399A2 true BRPI0518399A2 (pt) 2008-11-18

Family

ID=34930032

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518399-5A BRPI0518399A2 (pt) 2004-12-10 2005-12-08 produÇço de beta-lactama

Country Status (8)

Country Link
US (1) US20080131925A1 (pt)
EP (1) EP1819813A2 (pt)
KR (1) KR20070085955A (pt)
CN (1) CN101098963A (pt)
BR (1) BRPI0518399A2 (pt)
MX (1) MX2007006780A (pt)
SG (1) SG158108A1 (pt)
WO (1) WO2006061425A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293511B2 (en) * 2006-10-05 2012-10-23 Dsm Ip Assets B.V. Production of β-Lactam antibiotics
EP2080801A1 (en) * 2008-01-21 2009-07-22 Technical University of Denmark Production of non-ribosomal peptides in Saccharomyces
EP2123772A1 (en) * 2008-04-29 2009-11-25 DSM IP Assets B.V. Beta-lactam antibiotic producing strains
EP2376619A4 (en) 2008-12-15 2012-07-04 Greenlight Biosciences Inc METHODS FOR CONTROLLING FLOWS IN METABOLIC PATHWAYS
EP2379728A4 (en) * 2008-12-22 2016-04-13 Greenlight Biosciences Inc COMPOSITIONS AND METHOD FOR PRODUCING A COMPOUND
DK2566953T3 (en) 2010-05-07 2019-04-15 Greenlight Biosciences Inc METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
EP2611922A1 (en) 2010-08-31 2013-07-10 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
US9469861B2 (en) 2011-09-09 2016-10-18 Greenlight Biosciences, Inc. Cell-free preparation of carbapenems
BR112016002494A2 (pt) 2013-08-05 2017-09-05 Greenlight Biosciences Inc Proteí-nas construídas com um sítio de clivagem de protease, ácido nucléico, vetor, célula e processo de engenharia de uma proteína recombinante e de um grande número de variantes de ácidos nucleicos que codificam proteínas recombinantes
KR20180002636A (ko) 2015-03-30 2018-01-08 그린라이트 바이오사이언시스, 아이엔씨. 리보핵산의 무세포 생산
KR20230079463A (ko) 2016-04-06 2023-06-07 그린라이트 바이오사이언시스, 아이엔씨. 리보핵산의 무세포 생산
JP7186167B2 (ja) 2017-01-06 2022-12-08 グリーンライト バイオサイエンシーズ インコーポレーテッド 糖の無細胞的生産
KR20230130144A (ko) 2017-10-11 2023-09-11 그린라이트 바이오사이언시스, 아이엔씨. 뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327170C (en) * 1987-03-04 1994-02-22 Stephen Wyatt Queener Recombinant dna expression vectors and dna compounds that encode deacetoxycephalosporin c synthetase and deacetylcephalosporin c synthetase
GB8728811D0 (en) * 1987-12-09 1988-01-27 Beecham Group Plc Novel substance
US6258555B1 (en) * 1987-12-09 2001-07-10 Beecham Group P.L.C. DNA encoding ACV synthetase
US5882879A (en) * 1990-02-28 1999-03-16 Gist-Brocades, N.V. Method for influencing β-lactam antibiotic production and for isolation of large quantities of ACV synthetase

Also Published As

Publication number Publication date
KR20070085955A (ko) 2007-08-27
MX2007006780A (es) 2007-08-06
EP1819813A2 (en) 2007-08-22
WO2006061425A3 (en) 2006-08-03
US20080131925A1 (en) 2008-06-05
SG158108A1 (en) 2010-01-29
WO2006061425A2 (en) 2006-06-15
CN101098963A (zh) 2008-01-02

Similar Documents

Publication Publication Date Title
BRPI0518399A2 (pt) produÇço de beta-lactama
BRPI0520369A2 (pt) catalisador orgánico com compatibilidade intensificada de enzima
EP1926389B8 (en) Low ph aerated products
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
BRPI0418639A (pt) inibidores de dipeptidil peptidase
TR200101858T2 (tr) JNK protein kinaz inhibitörleri olarak 4-ariloksindoller
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
ECSP014105A (es) COMPUESTOS DE PIRROLO [2,3-d] PIRIMIDINA
GT200200043A (es) Nuevos compuestos antiinflamatorios de bencimidazol
ATE479687T1 (de) Kinaseinhibitoren
BRPI0600777A (pt) método e sistema para a criação, armazenamento, gerenciamento e consumo de dados especìficos de cultura
MY152283A (en) Polo-like kinase inhibitirs
BRPI0412894A (pt) tienopiridina e furopiridina inibidores de quinases
TW200700725A (en) Detection of nucleic acid associated with disease
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
MY147790A (en) Stable emulsion composition
ATE519849T1 (de) Herstellung von pravastatin
BRPI0604502A (pt) controles de ensino de metilação de gene
AU2003294253A8 (en) Emulsions including surface-modified organic molecules
ATE311397T1 (de) Sulfonamidomethyl phosphonat beta-lactamase inhibitoren
GB2453402A (en) Bis-pyyrolo[2.1.-c] benzodiazepine-anthraquinone conjugates as antitumour agents and a process for the preparation thereof
DE112008003640A5 (de) Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-Triazin-Derivaten
BR0211903A (pt) Isoxazolopiridinonas
WO2007030227A3 (en) Modified oligonucleotides containing diphosphodiester internucleotide linkages

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.